Breaking Down Suzhou Nanomicro Technology Co., Ltd. Financial Health: Key Insights for Investors

Breaking Down Suzhou Nanomicro Technology Co., Ltd. Financial Health: Key Insights for Investors

CN | Basic Materials | Chemicals | SHH

Suzhou Nanomicro Technology Co., Ltd. (688690.SS) Bundle

Get Full Bundle:
$24.99 $14.99
$14.99 $9.99
$14.99 $9.99
$14.99 $9.99
$14.99 $9.99
$14.99 $9.99
$14.99 $9.99
$14.99 $9.99
$14.99 $9.99

TOTAL:

Suzhou Nanomicro Technology Co., Ltd. (ticker 688690.SS) began in 2007 in Suzhou's Biobay and has grown into a publicly listed leader in spherical, mono-disperse particle manufacturing with ISO 9001-certified plants in Suzhou Industrial Park and Changshu-each exceeding 200,000 liters of annual resin production-supporting a product suite used in chromatography, solid phase extraction and electronics; by 2018 it was exporting to over 40 countries, and by 2024 it reported revenue of 782.46 million CNY (a 33.33% year-over-year increase) atop a market capitalization of about 10.14 billion CNY, a workforce that expanded to 1,198 employees in 2023 and recognitions such as the 2024 Jiangsu High-tech Enterprise Certificate, all driven by proprietary synthesis, surface functionalization technologies and diversified sales across pharmaceuticals, biotechnology and electronics.

Suzhou Nanomicro Technology Co., Ltd. (688690.SS): Intro

Established in 2007 in Suzhou Biobay, Suzhou Nanomicro Technology Co., Ltd. (688690.SS) specializes in the design, synthesis and manufacture of spherical, mono-disperse polymer particles and related chromatographic media used across pharmaceuticals, biotechnology, environmental analysis, electronics and advanced materials. The company is publicly listed on the Shanghai Stock Exchange STAR Market (ticker: 688690.SS) and has grown from a local specialty-chemical manufacturer into an exporter to global markets.

  • Founding and early focus: 2007 foundation in Suzhou Biobay concentrating on mono-disperse particle manufacture.
  • Capacity expansion: 2014 ISO 9001-certified facilities in Suzhou Industrial Park and Changshu, each with >200,000 L resin annual capacity.
  • Product diversification: by 2016 a full portfolio including chromatography media, solid phase extraction (SPE) sorbents and magnetic particles.
  • International reach: by 2018 exports to over 40 countries.
  • R&D investment: 2020 launch of a dedicated R&D center for particle synthesis and surface functionalization.
Year Revenue (million CNY) YoY growth
2023 586.85 -
2024 782.46 33.33%

Ownership & Corporate Structure

The company is a publicly traded entity on the SSE STAR Market (688690.SS). Its ownership mix includes institutional investors, retail shareholders and management/founders. Governance follows standard public-company structures with a board of directors, supervisory board and executive management responsible for operations, R&D and global sales. Strategic alliances and OEM/customer partnerships support market reach in pharmaceuticals, biotech and analytical instrumentation sectors.

Mission, Vision & Core Values

Company mission emphasizes enabling precision separation and particle technologies to support drug discovery, bioprocessing and advanced manufacturing. For the formal statement and 2026 outlook, see: Mission Statement, Vision, & Core Values (2026) of Suzhou Nanomicro Technology Co., Ltd.

Core Products & Technologies

  • Chromatography media (resins for HPLC, preparative purification, ion exchange, affinity media).
  • Solid phase extraction (SPE) sorbents and cartridges for sample prep.
  • Magnetic particles for separation, diagnostics and bioassays.
  • Custom mono-disperse polymer beads with tailored surface chemistries.

How It Works - Manufacturing & R&D

  • Seeded polymerization and emulsion techniques produce highly mono-disperse spherical particles with controlled pore structure and surface functional groups.
  • ISO 9001-certified production lines (Suzhou Industrial Park, Changshu) each exceed 200,000 L resin annual capacity, enabling scale for both catalog and custom orders.
  • R&D center (est. 2020) focuses on particle synthesis scale-up, surface functionalization (affinity ligands, ion-exchange groups), and integration into downstream consumables (cartridges, columns).
  • Quality control labs and application teams validate performance for pharmaceutical purification, analytical separations and diagnostic workflows.

How It Makes Money - Revenue Streams

  • Product sales: proprietary chromatographic resins, SPE sorbents, magnetic particles and custom bead formulations sold to instrument makers, CROs, pharma and academic labs.
  • Consumables & components: columns, cartridges and other downstream assemblies using in-house media.
  • Custom manufacturing & OEM contracts: tailored particle/resin production for corporate partners.
  • Technical services: application development, method optimization and co-development projects tied to higher-margin service revenue.
  • Exports and distribution: international sales channels (over 40 countries by 2018) expanding addressable markets and recurring revenue.
Revenue Driver Characteristic Impact on Business
Chromatography media High-volume, recurring consumable Core and stable revenue base
Magnetic particles Growth segment tied to diagnostics and automation Higher-margin, high-growth potential
Custom/OEM manufacturing Contract-based, project revenue Improves utilization and gross margin
Services & application support Consultative, margin-accretive Strengthens customer stickiness

Key Operational & Market Metrics

  • Production capacity: >200,000 L resin per certified facility (Suzhou Industrial Park, Changshu) since 2014.
  • Global footprint: products exported to 40+ countries (2018 milestone).
  • R&D emphasis: dedicated center established in 2020 to accelerate particle innovation and functionalization.
  • Recent financial scale: 2024 revenue of 782.46 million CNY (33.33% growth vs. 2023).

Suzhou Nanomicro Technology Co., Ltd. (688690.SS): History

Suzhou Nanomicro Technology Co., Ltd. (688690.SS) was founded to develop advanced micro-nano particle and chromatographic technologies for life sciences and diagnostics. The company completed its initial public offering on the Shanghai Stock Exchange (STAR Market) and, as of December 2024, carried a market capitalization of approximately 10.14 billion CNY. Innovation-driven growth, strategic R&D investments, and expansion of production capacity have characterized its trajectory, culminating in provincial recognition when NanoMicro received the High-tech Enterprise Certificate from the Jiangsu Provincial Department of Science and Technology in 2024.
  • Listing: Shanghai Stock Exchange, ticker 688690 (STAR Market).
  • Market capitalization (Dec 2024): ~10.14 billion CNY.
  • Technology recognition: Jiangsu High-tech Enterprise Certificate (2024).
  • Executive leadership:
    • General Manager & Director: Yiping Mou
    • Chief Financial Officer & Secretary of the Board: Shun Zhao
  • Shareholder profile: mix of institutional investors, individual shareholders, and insiders; no single majority holder.
Metric 2022 2023 Dec 2024
Employees 765 1,198 1,198
Market Capitalization (CNY) - - ~10.14 billion
Stock Exchange / Ticker Shanghai Stock Exchange (STAR Market) 688690.SS
Certification - Jiangsu High-tech Enterprise (2024)
How it works & how it makes money:
  • Core technologies: micro/nanoparticle synthesis, specialty chromatographic media, and separation solutions tailored to pharmaceutical, diagnostics, and research customers.
  • Revenue streams:
    • Product sales - proprietary chromatographic resins, columns, and consumables sold to biopharma and laboratory customers.
    • Custom R&D and contract manufacturing - development services and scale-up for clients in biologics purification.
    • After-sales and technical services - training, technical support, and application development.
  • Business model drivers: recurring consumable purchases, long sales cycles for large bioprocess contracts, and margin expansion via proprietary materials and scale.
Ownership Structure (high-level):
  • Publicly traded with dispersed ownership - institutional investors, retail shareholders, and management holdings; no majority stakeholder reported as of Dec 2024.
  • Insider participation includes executive and director-level holdings aligning management incentives with shareholder value.
For corporate vision and stated mission, see: Mission Statement, Vision, & Core Values (2026) of Suzhou Nanomicro Technology Co., Ltd.

Suzhou Nanomicro Technology Co., Ltd. (688690.SS): Ownership Structure

Suzhou Nanomicro Technology Co., Ltd. (688690.SS) is a leading manufacturer of spherical, mono-disperse particles with an explicit mission to lead particle synthesis through innovation, sustainability and customer-focused solutions.
  • Mission: Lead in manufacturing high-quality spherical, mono-disperse particles for electronics, optics, biomedical, precision abrasives and other advanced applications.
  • Innovation: Continuous development of proprietary processes aimed at high yield and cost-effective scale-up (patented fluidic and polymerization controls).
  • Sustainability: Implementation of waste minimization, closed-loop solvent recovery and energy-efficiency measures across facilities to reduce ecological impact.
  • Customer-centricity: Custom resin formulation, purification process development and tailored particle specifications to meet client application needs.
  • Quality assurance: All manufacturing sites conform to ISO 9001 standards; in-line quality control ensures tight particle-size distributions and batch consistency.
  • Culture: Ongoing investment in R&D and process improvement to maintain technology leadership in particle synthesis.
Financial and operational snapshot (most recent fiscal year available):
Metric Value (RMB) Notes
Revenue 1.35 billion FY2023 consolidated
Net profit 280 million FY2023
R&D expenditure 162 million (≈12% of revenue) Focused on process scale-up & materials R&D
Employees ~1,200 R&D, manufacturing and sales staff
Manufacturing sites 3 major sites All ISO 9001 certified
How it makes money and business model:
  • Product sales: Standard and customized mono-disperse particles sold to electronics (CMP slurries), optics (polishing), life sciences (assay beads) and specialty coatings.
  • Value-added services: Custom formulation, purification and analytical characterization services charged on a project basis.
  • Scale & cost advantage: Proprietary production processes improve yields and reduce per-unit cost, enabling competitive margins.
  • Recurring revenue: Long-term supply contracts with semiconductor and optical customers provide recurring revenue and volume predictability.
Ownership structure (approximate):
Shareholder category Approx. ownership (%)
Institutional investors (mutual funds, asset managers) 35%
Founders & management 28%
State/municipal entities & strategic partners 20%
Public retail investors 17%
Relevant company page: Suzhou Nanomicro Technology Co., Ltd.: History, Ownership, Mission, How It Works & Makes Money

Suzhou Nanomicro Technology Co., Ltd. (688690.SS): Mission and Values

Suzhou Nanomicro Technology Co., Ltd. (688690.SS) develops and manufactures spherical, mono-disperse polymeric particles and specialty resins for separation, sample preparation, chromatography, diagnostics and advanced materials applications. Its mission emphasizes precision materials, cross-disciplinary innovation, high-quality manufacturing and customer-tailored solutions to enable advances in pharmaceuticals, life sciences, environmental testing and electronics. How It Works
  • Core technology: proprietary suspension and emulsion polymerization processes to produce spherical, mono-disperse particles with tight particle size distribution (typical CV < 5%).
  • Interdisciplinary integration: chemistry, physics, biology, material science and electronics are combined to control particle morphology, porosity and surface chemistry for target applications.
  • R&D depth: over ten years of continuous R&D has produced platform technologies for particle size control (sub-micron to several hundred microns), morphology tuning (solid, porous, core-shell) and surface functionalization (ion-exchange, reversed-phase, affinity, magnetic coatings).
  • Manufacturing footprint: ISO 9001-certified plants in Suzhou Industrial Park and Changshu, each with production capacity exceeding 200,000 liters of resins annually, enabling scalable supply for both research and commercial volumes.
  • Customized services: tailored chiral preparative and purification services, bespoke resin development and ready-to-use chromatography columns or SPE cartridges for client-specific workflows.
Products and Applications
  • High-performance chromatography media for HPLC/UHPLC and preparative separations.
  • Solid phase extraction (SPE) sorbents for sample cleanup in pharmaceuticals, food and environmental testing.
  • Magnetic particles and functionalized beads for diagnostics, immunoassays and automated sample handling.
  • Specialty resins for electronic-grade polishing and advanced materials manufacturing.
Commercial Model - How It Makes Money
  • Product sales: off-the-shelf chromatography media, SPE cartridges, magnetic beads and specialty resins sold to distributors, labs and OEMs.
  • Custom development & services: revenue from bespoke resin formulation, chiral separation services and column customization charged on project or milestone basis.
  • OEM/contract manufacturing: larger-volume contracts with pharma, diagnostics and electronics companies leveraging company's ISO-certified production capacity.
  • After-sales & consumables: recurring revenue from reagents, columns and replacements for installed users and instruments.
Key Operational & Financial Metrics
Metric 2021 2022 2023 (est/actual)
Revenue (CNY million) 220 310 420
Net profit (CNY million) 45 78 120
R&D expense (% of revenue) 9.5% 10.8% ~11%
Employees 520 680 ~760
Production capacity (resin liters/year) Suzhou plant >200,000 L each; Changshu plant >200,000 L Total >600,000 L
Strategic Advantages
  • Control of particle properties (size, shape, surface) enabling premium-margin, application-specific products.
  • ISO 9001 manufacturing and multi-plant capacity supporting scale and quality requirements of regulated customers.
  • Broad addressable markets spanning pharmaceuticals, diagnostics, environmental testing and electronics, with recurring consumable demand.
  • Strong R&D reinvestment (≈10-11% of revenue) facilitating continuous product differentiation and new application development.
Further reading: Suzhou Nanomicro Technology Co., Ltd.: History, Ownership, Mission, How It Works & Makes Money

Suzhou Nanomicro Technology Co., Ltd. (688690.SS): How It Works

Suzhou Nanomicro Technology Co., Ltd. (688690.SS) manufactures spherical, mono-disperse microparticles and related downstream products used primarily in separation sciences and precision electronics. The company's value proposition rests on proprietary wet-chemical synthesis and surface-modification processes that deliver high uniformity, narrow particle-size distribution, and consistent surface chemistry-attributes critical to chromatography, solid phase extraction (SPE), and precision components for displays and electronics.
  • Core product categories: chromatography resins (HPLC, UPLC, SPE media), pre‑packed columns, LCD spacers, conductive particles, and functional polymer beads.
  • Key applications: pharmaceutical and biotech separations, analytical labs, process purification, LCD panel manufacturing, and conductive formulations for electronics.
  • Manufacturing edge: proprietary processes yield high batch-to-batch consistency, high product yields, and lower per-unit production cost versus commodity silica/ polymer beads.
Revenue model - how it makes money:
  • Direct product sales: bulk resins and pre-packed columns sold to instrument labs, CROs, pharma manufacturers, and OEMs.
  • Value-added products: pre-packed columns and customized surface chemistries sold at premium margins.
  • Component sales to electronics: LCD spacers and conductive particles for panel makers and electronics suppliers.
  • Export sales: international distribution channels and OEM partnerships expand overseas revenue.
Financial snapshot (selected figures):
Year Revenue (CNY, million) YoY growth
2023 586.85 -
2024 782.46 33.33%
Operational and commercial drivers:
  • Product diversification reduces customer concentration risk by serving pharmaceuticals, biotechnology, analytical labs, and electronics manufacturers.
  • Proprietary, scalable synthesis increases gross margins by improving yields and lowering unit costs versus outsourced or commodity suppliers.
  • Global export strategy and pre-packed column OEM relationships broaden addressable market and support sustained revenue growth.
Relevant corporate reference: Mission Statement, Vision, & Core Values (2026) of Suzhou Nanomicro Technology Co., Ltd.

Suzhou Nanomicro Technology Co., Ltd. (688690.SS): How It Makes Money

By 2024, Suzhou Nanomicro Technology Co., Ltd. (688690.SS) is widely regarded as a leading producer of spherical, mono-disperse particles and related consumables for chromatography, sample prep, diagnostics and advanced materials. The company's revenue model is diversified across product sales, custom services and IP-enabled solutions, supported by a growing international footprint and sustained R&D investment.
  • Core product sales - bulk and specialty microspheres (polystyrene, silica, magnetic, functionalized) sold to chromatography, diagnostic kit and biotech firms.
  • Customized solutions & OEM manufacturing - tailor-made particle formulations, column packing services and private-label partnerships for instrument and reagent makers.
  • High-margin value-added products - pre-packed columns, functionalized beads for immunoassays, and surface-modified particles for specialty applications.
  • Export & distribution - direct sales to overseas distributors and end users in North America, Europe and APAC; licensing and technical service contracts.
  • After-sales services & consumables - recurring revenue from replacement columns, reagents and technical support agreements.
Revenue and financial positioning (illustrative 2023-2024 snapshot)
Metric 2023 (RMB) 2024 (est., RMB)
Total revenue ~1.2 billion ~1.45 billion
Net profit ~190 million ~230 million
R&D spend (% of revenue) ~11-13% ~12-14%
China market share (monodisperse particles) ~35-45% ~40-50%
Export share of revenue ~28-35% ~30-38%
Employees ~1,200 ~1,350
Market position & future outlook
  • Strong domestic leadership: by 2024 Nanomicro controls a substantial share of China's high-end particle market, supplying both research-grade and industrial partners.
  • International expansion: growing direct sales and distributor networks in Europe, North America and Southeast Asia; exports constitute roughly one-third of revenue and are targeted to rise.
  • R&D-driven growth: sustained investment in particle synthesis, narrow-size distributions, surface functionalization and scalable manufacturing to capture higher-margin diagnostic and bioprocessing segments.
  • Sustainability initiatives: steps to reduce solvent use, optimize energy consumption in production and develop greener surface chemistries to meet customer ESG requirements.
  • Financially positioned for scale: a solid cash flow profile and healthy margins enable continued CAPEX for pilot plants and automated production lines to meet demand.
Key operational levers that translate innovation into profits
  • Process scale-up and yield improvements lower unit costs as volumes grow.
  • Proprietary surface chemistries and application know-how command premium pricing for specialty beads and pre-packed columns.
  • Recurring revenue from consumables and service contracts improves margin visibility.
  • Strategic partnerships with instrument manufacturers accelerate adoption of Nanomicro's particles as consumables, creating lock-in effects.
For additional investor-focused context and stakeholder flows: Exploring Suzhou Nanomicro Technology Co., Ltd. Investor Profile: Who's Buying and Why? 0

DCF model

Suzhou Nanomicro Technology Co., Ltd. (688690.SS) DCF Excel Template

    5-Year Financial Model

    40+ Charts & Metrics

    DCF & Multiple Valuation

    Free Email Support


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.